IHS Chemical Week

World News and Views :: Top of the News

Solvay Shareholder Denies Approach from Sanofi-Aventis

10:33 AM MDT | April 2, 2009 | Natasha Alperowicz

Solvac (Brussels), the family owned holding vehicle, which controls 30.07% in Solvay, has denied press reports that it has been approached about the potential sale of Solvay's pharmaceuticals business. "Solvac denies any contact with third parties about the sale of its participation in Solvay, in part or in total," the company said today. A report in the Financial Times stated that Sanofi-Aventis has made a direct approach to Solvac but that Solvac rejected the offer, which valued the whole company at €7.2 billion ($9.6...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa